5/23/2024AstraZeneca Aims to Leverage China's Surge in Innovation to Enhance It...

5/23/2024NMPA Issues Announcement for Applicability of ICH Guidelines Q5A(R2)

5/23/2024CDE Issues the List of Reference Formulations for GQCE Studies (80th B...

5/23/2024Takeda and Degron Thera Strike $1.2B Licensing Pact for Molecular Glue...

5/23/2024Russia and China to Co-develop New Drugs against Treatment-resistant B...

5/23/2024Bayer to Build Consumer Healthcare Products Supply Center in China

5/23/2024Report on China's Commercial Health Insurance Highlights Younger Demog...

5/23/2024Hong Kong Emerges As Global Health Innovation Hub Under China New Plan...

5/22/2024MaxCyte Signs Platform License Deal with Legend to Accelerate Cell The...

5/22/2024Nona Bio and AstraZeneca Strike Global License Deal for mAb to be Dev...

5/21/2024NMPA and NHC Issue Notice to Strengthen Regulation of Psychotropics In...

5/21/2024China's Investigator Trials Accelerate Competitive CAR T Development (...

5/21/2024With $5B in China Sales, AstraZeneca Doubles Down on Chinese Biopharma...

5/21/2024Chinese Biotechs Remain Optimistic About Cross-border Cooperations Des...

5/20/2024AZ to Build US$1.5B Cancer Drug Plant In Singapore, Reduce Industry's ...

5/20/2024China Set to Ease Controls on Genetic Resources to Plug Biotech Innova...

5/20/2024Sol-Gel and Beimei Pharma Strike Deal to Commercialize TWYNEO in Great...

5/20/2024NMPA and South Korean Ministry of Food and Drug Safety Renew MOU for R...

5/20/2024CDE Releases the Annual Report on New Drug Registration Clinical Trial...

5/20/2024NHSA Issues New Policy to Expand and Improve Centralized VBP for Drugs...

5/20/2024Duoning Bio to Commercialise Single-cell Sorting System for Antibody D...

5/17/2024China's Healthcare Reform: Opening Doors to Foreign Investment in Hosp...

5/17/2024Mainland China and Macao Seek to Boost Healthcare Integration

5/17/2024Charting China's Healthcare AI Advantage: A Comparative Perspective

5/17/2024Four Investors Inject $400M into Biotech Startup Securing Weight Loss ...

5/17/2024Setback for China-Made PD-1 Inhibitors as FDA Rejects Hengrui and Elev...

5/17/2024Erasca Announces Strategic In-Licensing of RAS-Targeting Franchise

5/17/2024Performance Review of A Share-Listed Chinese MedPharm Cos in 2023

5/17/2024China Issues Warning about Spread of Dengue

5/17/2024GVSAP and Biocytogen to Accelerate Biopharma Innovation

Page:79/790 Total number of articles:23678: [First][<<] [77] [78] [79] [80] [81] [>>] [End]